Morepen Laboratories LimitedNSE: MOREPENLAB

Press Release Mar 17 2025

· Issued by Morepen Laboratories Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Morepen Laboratories Limited has issued a press release announcing the launch of Empamore, a new treatment for diabetes and related conditions. Empamore is manufactured in USFDA-approved facilities and is positioned as a cost-effective alternative to existing treatments.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Morepen Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment ".

Morepen Laboratories Limited on 6ix

Earlier from Morepen Laboratories

Later from Morepen Laboratories

All Morepen Laboratories news releases